Medical specialists from France tagged as investigators in clinical trials studying Leiomyosarcoma
Total 5 results
-
Antoine ItalianoSeen in:
- Aquitaine, Bordeaux, Institut Bergonié - Centre Régional de Lutte Contre Le Cancer de Bordeaux et Sud Ouest
- Bordeaux Cedex, Institut Bergonie
- Bordeaux, Bergonie Institute
- Bordeaux, Institut Bergonie
- Bordeaux, Institut Bergonié - Centre Régional de Lutte Contre Le Cancer de Bordeaux et Sud Ouest
Trials:- NCT05009927 (Principal Investigator)
- NCT03906331 (Principal Investigator)
- NCT05440786 (Principal Investigator)
- NCT05269355 (Principal Investigator)
- NCT02834884 (Principal Investigator)
- NCT03157128 (Principal Investigator)
- NCT02029001 (Principal Investigator)
- NCT04104776 (Principal Investigator)
- NCT05920408 (Principal Investigator)
- NCT05999994 (Principal Investigator)
Conditions:- C-KIT Mutation;
- Metastatic Gastrointestinal Stromal Tumor (GIST);
- Advanced Gastrointestinal Stromal Tumor (GIST);
- Breast Cancer;
- Pancreatic Cancer;
- Non Small Cell Lung Cancer;
- Colon Cancer;
- Medullary Thyroid Cancer;
- Papillary Thyroid Cancer;
- Other Solid Tumors With Evidence of Activating RET Alteration;
- Neoplasm Metastasis;
- Sarcoma, Ewing;
- Leiomyosarcoma;
- All Tumor Types;
- Non-Small Cell Lung Cancer;
- Any Solid Tumor;
- Malignant Solid Neoplasms;
- Lymphoma, T-Cell;
- Mesothelioma, Malignant;
- Advanced Solid Tumor;
- Endometrial Cancer;
- Diffuse Large B Cell Lymphoma;
- Ovarian Clear Cell Carcinoma;
- Prostatic Neoplasms, Castration-Resistant;
- Advanced Solid Tumours;
- Adolescent;
- Neoplasms;
- Child
-
Benjamin VerretSeen in:
- Villejuif cedex, Gustave Roussy
- Villejuif, Gustave Roussy
Trials:- NCT05269355 (Principal Investigator)
- NCT05041842 (Principal Investigator)
-
Jean Yves Blay, MDSeen in:
- Lyon, Centre LEON BERARD
Trials:- NCT02275286 (Principal Investigator)
-
Jean-Yves BlaySeen in:
- Lyon, Centre LEON BERARD
Trials:- NCT05269355 (Principal Investigator)
- NCT02834884 (Principal Investigator)
Conditions: -
Sarah WatsonSeen in:
- Paris, Institut Curie
Trials:- NCT05269355 (Principal Investigator)
- NCT04921553 (Principal Investigator)
Conditions:- Leiomyosarcoma;
- Cancer;
- Cancer Metastatic;
- ALK Fusion Protein Expression;
- FGFR2 Gene Translocation;
- FGFR3 Gene Translocation;
- NTRK Family Gene Mutation;
- Gene Fusion;
- ROS1 Gene Translocation;
- NTRK Gene Fusion Overexpression;
- ATIC-ALK Fusion Protein Expression;
- BCR-FGFR1 Fusion Protein Expression;
- COL1A1-PDGFB Fusion Protein Expression;
- RET Gene Translocation;
- ROS Gene Translocation;
- BRAF Gene Rearrangement;
- NTRK1 Gene Translocation
Clinical Trials on Leiomyosarcoma
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)RecruitingLocally Advanced Leiomyosarcoma | Metastatic Leiomyosarcoma | Stage III Uterine Corpus Leiomyosarcoma AJCC v8 | Stage IV Uterine Corpus Leiomyosarcoma AJCC v8 | Unresectable Leiomyosarcoma | Uterine Corpus LeiomyosarcomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingMetastatic Leiomyosarcoma | Unresectable Leiomyosarcoma | Uterine Corpus LeiomyosarcomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingMetastatic Leiomyosarcoma | Stage III Uterine Corpus Leiomyosarcoma AJCC v8 | Stage IV Uterine Corpus Leiomyosarcoma AJCC v8 | Unresectable Leiomyosarcoma | Stage IIIA Uterine Corpus Leiomyosarcoma AJCC v8 | Stage IIIB Uterine Corpus Leiomyosarcoma AJCC v8 | Stage IIIC Uterine Corpus Leiomyosarcoma... and other conditionsUnited States
-
National Cancer Institute (NCI)RecruitingLocally Advanced Uterine Corpus Leiomyosarcoma | Metastatic Uterine Corpus Leiomyosarcoma | Stage III Uterine Corpus Leiomyosarcoma AJCC v8 | Stage IV Uterine Corpus Leiomyosarcoma AJCC v8 | Unresectable Uterine Corpus LeiomyosarcomaUnited States, Puerto Rico
-
Gustave Roussy, Cancer Campus, Grand ParisCompletedUterus Leiomyosarcoma | Soft Tissue LeiomyosarcomaFrance
-
National Cancer Institute (NCI)Active, not recruitingStage III Uterine Corpus Leiomyosarcoma AJCC v8 | Stage IV Uterine Corpus Leiomyosarcoma AJCC v8 | Uterine Corpus LeiomyosarcomaUnited States
-
Kristen GanjooRecruitingUterine Leiomyosarcoma | LMS - LeiomyosarcomaUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); EMD SeronoTerminatedMetastatic Leiomyosarcoma | Unresectable Leiomyosarcoma | Metastatic Liposarcoma | Unresectable LiposarcomaUnited States
-
David Liebner, MDWithdrawnLocally Advanced Leiomyosarcoma | Metastatic Leiomyosarcoma | Unresectable Leiomyosarcoma | Stage III Retroperitoneal Sarcoma AJCC v8 | Stage IIIA Retroperitoneal Sarcoma AJCC v8 | Stage IIIB Retroperitoneal Sarcoma AJCC v8 | Stage IV Retroperitoneal Sarcoma AJCC v8United States
-
Gachon University Gil Medical CenterMerck KGaA, Darmstadt, Germany; Chong Kun Dang Pharmaceutical Corp.RecruitingLeiomyosarcoma MetastaticKorea, Republic of